JPRN-UMIN000000971已完成未知
Clinical study of intratumoral dendritic cells(DC) injection after radiofrequency ablation(RFA) therapy for the treatment of hepatitis C virus-related hepatocellular carcinoma(HCC) patients - Intratumoral DC injection after RFA for the treatment of HCC
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 10
研究概览
简要总结
Three patients with advanced hepatocellular carcinoma received intratumoral injections of dendritic cells after radiofrequency ablation therapy. In this study, no serious adverse event was observed. The treatment was safe and feasible.
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Patients who have: - Interstitial pneumonia, pulmonary fibrosis, or drug-induced pneumonia , or predisposition to them; - Continuous systemic administration of steroids; - Active autoimmune diseases or predisposition to them; - Other cancers; - Uncontrolled infection
研究者
相似试验
已完成
不适用
Clinical study of intratumoral dendritic cell injection after radiofrequency ablation therapy in hepatitis C virus-related hepatocellular carcinoma patientsHepatocellular carcinomaJPRN-C000000451Tokyo Medical University5
未知
1 期
Dendritic cell therapy and intratumor dendritic cell injection therapy using Tumor associated antigen or tumor lysate for patients with advanced and recurrent canceradvanced and recurrent cancerJPRN-UMIN000000775Fukushima Medical University25
已完成
1 期
Phase I/II Intratumoral DC Immunotherapy With Gemcitabine & XRT in Unresectable Pancreatic CancerPancreatic CancerNCT00547144George Albert Fisher2
撤回
1 期
Intratumoral Dendritic Cell Vaccination Combined With Local Radiotherapy in Patients With Recurrent Lymphoma.LymphomaNCT00637117Baylor Research Institute
Unknown
2 期
Phase II Study With Immunotherapy With Dendritic Cells and Tumor Infiltrating Lymphocytes in Solid TumorsCarcinoma, HepatocellularMelanomaRenal Cell CarcinomaNCT00610389Clinica Universidad de Navarra, Universidad de Navarra27